Trademark: 79263121
Word

Status
Registered
Status Code
700
Status Date
Tuesday, February 9, 2021
Serial Number
79263121
Registration Number
6263286
Registration Date
Tuesday, February 9, 2021
Mark Type
2000
Filing Date
Friday, October 12, 2018
Published for Opposition
Tuesday, November 24, 2020

Trademark Owner History
Roivant Sciences GmbH - Original Registrant

Classifications
9 Downloadable computer software using artificial intelligence for the conversion, analysis, processing, storage and transmission of electronic data in the fields of public health, healthcare and biomedical research; downloadable software for data analytics in the fields of public health, healthcare, pharmaceutical and biomedical research and development and downloadable software for statistical analysis of clinical trials as well as post-authorization research for the marketing of medicines and/or commercial post-launching of medicines and provision of medical and healthcare services; downloadable computer software for use in managing and integrating computer databases of pharmaceuticals and medical information; downloadable computer software for use in customer relationship management and database management of medical practices and research; downloadable computer search engine software for accessing and providing updated scientific, medical and clinical information, and news information of general interest; computer software for accessing data and information related to healthcare services and patient medical information and for controlling and managing data and information related to healthcare services and patient medical information; downloadable computer software for measuring, monitoring, processing and tracking health, wellness and medical information
35 Business research and information services in the fields of public health, healthcare and biomedical research; market research and information service in the fields of public health, healthcare and biomedical research; data processing services in the fields of public health, healthcare and biomedical research; analysis of business data in the fields of public health, healthcare and biomedical research; statistical analysis for business purposes, documentation being a compilation of statistics, and professional business consultancy services regarding statistics for biomedical research, healthcare institutions and healthcare professionals, based on artificial intelligence and machine learning; business analysis and statistical analysis for business purposes relating to healthcare data, biomedical research and clinical trial data; computerized data processing; business research, market testing being market research and statistical analysis for business purposes in the fields of public health, healthcare, biomedicine and clinical trials; advertising, marketing and sales promotion services for the pharmaceutical and medical products of others; providing business intelligence services in the fields of pharmaceuticals, biomedicine, clinical trials, post-authorization research for the marketing of medicines and/or commercial post-launching of medicines, epidemiological research, pharmacoepidemiological research, public health and healthcare; providing information regarding market intelligence services and competitive intelligence services in the fields of pharmaceuticals, public health and healthcare from an on-line database
41 Educational services, namely arranging, conducting and organizing classes, seminars, conferences, symposiums and training workshops in the field of healthcare and pharmaceuticals to promote the exchange of information and resources within the scientific research and medical communities to achieve advances in the fields of healthcare and pharmaceuticals, and distribution of training materials in connection therewith
42 Scientific and technological services, namely, research in the fields of public health, healthcare and biomedical research; scientific research in the field of pharmaceuticals, biological therapeutic products, and clinical trials, and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines and epidemiology; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials, post-authorization research for the marketing of medicines and/or commercial post-launching of medicines and epidemiology; providing temporary use of online non-downloadable computer software for use in managing and integrating computer databases of pharmaceuticals and medical information; providing temporary use of online non-downloadable computer software for use in customer relationship management and database management of medical practices and research; providing temporary use of online non-downloadable computer search engine software for accessing and providing updated scientific, medical and clinical information, and news information of general interest; providing temporary use of online non-downloadable computer software for accessing data and information related to healthcare services and patient medical information and for controlling and managing data and information related to healthcare services and patient medical information
44 Providing health and medical information; providing internet-based healthcare information; providing medical information to healthcare professionals regarding patient data; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical and biological products for the prevention and treatment of diseases, disorders and conditions; medical services; medical services, namely, providing medical services and consultation over the telephone and via the Internet through the use of personal computers, smartphones, tablets, mobile and wireless devices, and other telecommunication devices; pharmaceutical advice; conduct of medical and pharmaceutical consultations; medical assistance services in the nature of medical information provided to medical professionals from remote locations via the Internet and global computer networks through the use of a data storage and retrieval system
The color(s) lavender blue and violet is/are claimed as a feature of the mark.
The mark consists of a circle shaded in violet with a lavender blue geometric shape consisting of two circles connected by a diagonal line tilted to the right at a forty-five degree angle, so that the bottom portion of the geometric shape is directly to the left of the violet circle and the top portion of the geometric shape is directly above the violet circle.

Trademark Events
May 30, 2021
Final Decision Transaction Processed By Ib
May 11, 2021
Final Disposition Notice Sent To Ib
May 11, 2021
Final Disposition Processed
May 9, 2021
Final Disposition Notice Created, To Be Sent To Ib
Feb 9, 2021
Registered-Principal Register
Nov 24, 2020
Official Gazette Publication Confirmation E-Mailed
Nov 24, 2020
Published For Opposition
Nov 21, 2020
Notification Processed By Ib
Nov 4, 2020
Notification Of Possible Opposition Sent To Ib
Nov 4, 2020
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Nov 4, 2020
Notification Of Notice Of Publication E-Mailed
Oct 21, 2020
Approved For Pub - Principal Register
Oct 21, 2020
Teas/Email Correspondence Entered
Oct 20, 2020
Correspondence Received In Law Office
Oct 20, 2020
Teas Request For Reconsideration Received
Apr 20, 2020
Notification Of Final Refusal Emailed
Apr 20, 2020
Final Refusal E-Mailed
Apr 20, 2020
Final Refusal Written
Mar 17, 2020
Teas/Email Correspondence Entered
Mar 16, 2020
Correspondence Received In Law Office
Mar 16, 2020
Teas Response To Office Action Received
Dec 13, 2019
New Representative At Ib Received
Nov 6, 2019
Attorney Review Completed
Nov 5, 2019
Correction From Ib Entered - Attorney Review Required
Oct 18, 2019
Correction Transaction Received From Ib
Oct 12, 2019
Refusal Processed By Ib
Oct 4, 2019
New Representative At Ib Received
Sep 14, 2019
Non-Final Action Mailed - Refusal Sent To Ib
Sep 14, 2019
Refusal Processed By Mpu
Sep 7, 2019
Non-Final Action (Ib Refusal) Prepared For Review
Sep 6, 2019
Non-Final Action Written
Aug 6, 2019
Application Filing Receipt Mailed
Jul 31, 2019
Assigned To Examiner
Jul 31, 2019
New Application Office Supplied Data Entered In Tram
Jul 29, 2019
Limitation From Original Application Entered
Jul 18, 2019
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24